MBS review targets 'sleep disorder businesses'
13th September 2016
The MBS Review Taskforce is taking aim at corporate sleep testing clinics that sell patients expensive CPAP devices without them ever being seen by a specialist.

In its review of sleep study MBS items, a taskforce committee identified a small number of medical corporates with a high volume of claims for home-based sleep investigations for obstructive sleep apnoea (OSA).
It found 67% of patients who had a home-based sleep investigation for OSA did not have a consultation with a sleep specialist 12 months before or after the investigation.